Isofol Medical AB (publ)

OM:ISOFOL Stock Report

Market Cap: kr116.0m

Isofol Medical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Petter Lindqvist

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued

May 18
An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued

Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation

Nov 09
Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation

Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?

May 12
Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?

Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)

Apr 08
Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)

Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment

Mar 03
Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment

We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully

Jan 10
We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully

CEO

Petter Lindqvist

less than a year

Tenure

Mr. Petter Segelman Lindqvist serves as Chief Executive Officer of Isofol Medical AB (publ) since January 09, 2024. He is Chief Executive Officer of Hamlet BioPharma AB (publ) (formerly known as Hamlet Pha...


Leadership Team

NamePositionTenureCompensationOwnership
Petter Lindqvist
Chief Executive Officerless than a yearno datano data
Magnus Hurst
Chief Financial Officerless than a yearno datano data
Roger Tell
Chief Medical Officerless than a yearno data0.0031%
SEK 3.6k

0.3yrs

Average Tenure

Experienced Management: ISOFOL's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jan-Eric Österlund
Independent Chairmanless than a yearkr996.00k0.40%
SEK 459.5k
Sten Nilsson
Independent Directorless than a yearno datano data
Lars Lind
Independent Directorless than a yearkr29.00kno data
Alain Herrera
Independent Directorless than a yearkr271.00kno data
Helena Taflin
Independent Directorless than a yearno datano data

0.3yrs

Average Tenure

76.5yo

Average Age

Experienced Board: ISOFOL's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.